Clinical Trial Update: A Phase II/III Study of Adebrelimab in Combination With SHR-8068 and Chemotherapy in Advanced or Metastatic NSCLC Patients [Phase 2, Phase 3]

View source ↗

Summary

A Phase II/III clinical trial evaluating Adebrelimab in combination with SHR-8068 and chemotherapy for advanced or metastatic non-squamous non-small cell lung c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Adebrelimab (adebrelimab)
• SHR-8068

Snippet

Sponsor: Shanghai Shengdi Pharmaceutical Co., Ltd | Conditions: Non-squamous Non-small Cell Lung Cancer | Phase 2, Phase 3 | Status: NOT_YET_RECRUITING